Related Experiment Video
Updated: Nov 4, 2025

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
Published on: March 10, 2017
Inflammation can increase hepcidin in HFE-hereditary hemochromatosis
Wenke Moris1,2,3, Pauline L M Verhaegh2,3, Ad A M Masclee2,3
1Department of Internal Medicine, Gastroenterology and Clinical Geriatrics Zuyderland Medical Center Sittard-Geleen The Netherlands.
This study shows how inflammation can raise hepcidin levels in a patient with a specific HFE gene mutation. This suggests the JAK/STAT3 pathway may override normal iron regulation during illness.
Area of Science:
- Biochemistry
- Genetics
- Immunology
Background:
- Hepcidin is a key regulator of iron homeostasis.
- Hereditary hemochromatosis is linked to HFE gene mutations.
- Systemic inflammation typically alters iron metabolism.
Observation:
- A patient with homozygous p.C282Y HFE mutation presented with elevated hepcidin during systemic inflammation.
- Despite high hepcidin, iron parameters were normal.
- The BMP/SMAD pathway, crucial for HFE function, was likely impaired.
Findings:
- Inflammation can upregulate hepcidin even with a non-functional HFE gene.
- The JAK/STAT3 pathway is a probable mechanism for this inflammation-induced hepcidin increase.
- This suggests alternative pathways can influence hepcidin levels.
Implications:
- Understanding these alternative regulatory pathways is crucial for managing iron disorders.
- This finding may inform therapeutic strategies for iron dysregulation in inflammatory conditions.
- Further research into the JAK/STAT3 role in hepcidin regulation is warranted.
More Related Videos
05:08Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test